Quotient Sciences, a drug developer and manufacturer, announced that it has completed an expansion of its early-phase formulation development capabilities for oral dosage forms at its Nottingham, UK, facility.
The expanded services build upon the site's existing formulation capabilities and increase capacity to support fully integrated drug development programs. With this latest investment, the company has expanded its high containment laboratory capacity to support oral drug programs including immediate release, modified release tablet and multi-particulate dosage forms for highly potent compounds.